Two Biotech ETFs: One Stands Out as the other Forges a Big Continuation Pattern

Even though the Biotech ETF (IBB) and the Biotech SPDR (XBI) represent the same industry group, their composition is very different and one is clearly outperforming the other. Nevertheless, the laggard still has a big bullish continuation pattern and this group looks bullish as a whole.

First, let’s consider the differences. IBB is dominated by large-cap biotechs because the top ten holdings account for around 46%. XBI, in contrast, is more equally weighted because the top ten holdings account for just 14.5%. IBB represents large-cap biotechs, such as AMGN, GILD, REGN, VRTX, ILMN and BIIB. XBI represents the “average” biotech and the industry group as a whole.

The chart above shows XBI with a new high in October and again here in November. The chart shows three bullish consolidations and three breakouts along the way. The indicator window shows the XBI:IBB ratio moving higher since mid March and hitting a new high this month. This shows that XBI is outperforming IBB.

The next chart shows IBB with lower highs from June to October and October to November. Even though IBB is underperforming XBI, the bigger trend is up and the large triangle is viewed as a bullish continuation pattern. In other words, it is just a rest within the bigger uptrend. Moreover, a smaller bullish pattern is taking shape within the triangle. IBB surged, formed a small pennant and is making a breakout attempt.

Looking for more setups like these? Check out trendinvestorpro.com. Each week we dissect our master chart list and group the ETFs according to trends, patterns and setups. Thursday’s report includes dozens of annotated charts with commentary. Subscribers also have access to quantified trend-momentum strategies and the weekly video on Saturdays.

Click here to take your analysis process to the next level!

Two ETFs with Market Leading Charts and Fast Growing Industries

New highs and a fast growing industry group make for a powerful combination. Today’s article will focus on two ETFs that capture two fast growing industries, video gaming and esports. We will show why these two ETFs are leading, why a consolidation within an uptrend is bullish and why a 50-day SMA is better suited for mean-reversion trading.

Two ETFs with Market Leading Charts and Fast Growing Industries Read More »

The Setup to Anticipate the Breakout – XME Example

Chartists are often faced with a choice: wait for the breakout or anticipate using a mean-reversion setup. The Metals & Mining SPDR (XME) broke out of a bullish consolidation this week and the breakout signals a continuation of its long-term uptrend. Chartists keying off the mean-reversion setup could have anticipated the breakout and gotten the early jump. Let’s investigate.

The Setup to Anticipate the Breakout – XME Example Read More »

Silver Crosses Turn Dull

There are fewer silver crosses in the major stock indexes and this shows less participation during the last leg higher. A silver cross occurs when the 20-day EMA crosses above the 50-day EMA. DecisionPoint took this concept on step further and developed breadth indicators based on the percentage of stocks with silver crosses. This is a great way to look under the hood and aggregate medium-term trend performance for each index. The chart below shows this indicator for four key indexes: $NDX, $SPX, $MID and $SML. I set the bullish and bearish thresholds at

Silver Crosses Turn Dull Read More »

Trend Composite Turns Fully Bullish for Verizon

Verizon (VZ) participated in the first leg up from late March to mid April, but then stumbled with a decline into mid June. This stumble, however, looks like a classic correction and the stock broke out with a strong move over the last six weeks. In addition, the TIP Trend Composite, which aggregates five trend-following indicators turned positive in early August. Let’s investigate further.

Trend Composite Turns Fully Bullish for Verizon Read More »

Four Stocks Poised to Drive Healthcare Higher

The Healthcare SPDR (XLV) is one of the strongest sectors in 2020. Even though it does not sport the biggest gain, XLV recorded a new high in July and some 80% of its components are above their 200-day EMAs. The new high points to a long-term uptrend and upside leadership, while the percentage of stocks above the 200-day EMA points to broad strength within the sector. Sector SPDRs, however, are only as strong as the sum of their parts (component stocks).

Four Stocks Poised to Drive Healthcare Higher Read More »

A Bollinger Band Breakout or the Dreaded Head Fake?

There were a number of Bollinger Band squeeze plays over the last two weeks and also a number of breakouts. These breakouts are bullish until proven otherwise, but chartists should also be aware of the head fake. In his book, Bollinger on Bollinger Bands, here’s how John Bollinger puts it: Traders beware! There is a trick to The Squeeze, an odd turning of the wheel that you need to be aware of, the head fake.

A Bollinger Band Breakout or the Dreaded Head Fake? Read More »

Knowing When to Add Risk and When to Reduce Risk

The S&P 500 is the most widely used benchmark for the US stock market and the 200-day SMA is perhaps the most widely used moving average. These two came together again in late May as the index crossed back above on May 27th. Today we quantify the performance of prior signals and show how a little smoothing can go a long way. Furthermore, a simple market timing mechanism can tell investors when to add risk and when to seek alternatives to stocks.

Knowing When to Add Risk and When to Reduce Risk Read More »

Timing S&P 500 Swings Using the Bullish Percent Index

The Bullish Percent Index is a breadth indicator that quantifies double top breakouts and double bottom breakdowns, Point & Figure style. Basically, this indicator measures higher highs (breakouts) versus lower lows (breakdowns). This makes it a great candidate to quantify underlying strength and weakness in the S&P 500. There have been three signals in the last few months and one triggered this week.

Timing S&P 500 Swings Using the Bullish Percent Index Read More »

Big Biotechs Make a Big Statement

The two most popular biotech ETFs are leading the market this month and making big statements. Before looking at these two, note that they are quite different. The Biotech ETF (IBB) is dominated by large-cap biotechs with the top ten holdings accounting for over 50%. The Biotech SPDR (XBI), on the other hand, is a broad-based ETF with the top ten holdings accounting for less than 25% of the ETF.

Big Biotechs Make a Big Statement Read More »

Scroll to Top